このエントリーをはてなブックマークに追加


ID 68980
フルテキストURL
suppl1.docx 23.3 KB
suppl2.docx 31.6 KB
著者
Harada, Ko Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai
Vu, Quynh Thi Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Nishimura, Yoshito Division of Hematology/Oncology, Mayo Clinic
Takeda, Tatsuaki Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University
Hamano, Hirofumi Department of Pharmacy, Okayama University Hospital
Minato, Yusuke Center for Infectious Disease Research, Fujita Health University
Zamami, Yoshito Department of Pharmacy, Okayama University Hospital ORCID Kaken ID publons researchmap
Koyama, Toshihiro Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Hagiya, Hideharu Department of Infectious Diseases, Okayama University Hospital ORCID Kaken ID researchmap
抄録
Objectives: To examine the international trends for nontuberculous mycobacterial-associated mortality rates, as nontuberculous mycobacterial infections are becoming increasingly prevalent and pose a significant public health challenge, especially in older populations.
Methods: This retrospective observational study used data from the World Health Organization mortality database, which included patients with nontuberculous mycobacterial infection in 83 countries. We stratified the data by sex, age, and geographic region and calculated crude and age-standardized mortality rates to estimate long-term mortality trends.
Results: In total, 42,182 nontuberculous mycobacterial infection-associated deaths (58.1% in women) were reported in 83 countries between 2000 and 2022. The locally weighted regression model estimation for the nontuberculous mycobacterial infection-associated mortality rate more than doubled—from 0.36 deaths per 1000,000 individuals in 2000 to 0.77 deaths per 1000,000 individuals in 2022. Eighty-six percent of nontuberculous mycobacterial infection-associated deaths occurred in people aged ≥65 years. The mortality rate was the highest in the Western Pacific Region.
Conclusion: This study highlights the impact of emerging nontuberculous mycobacterial diseases and the importance of targeted interventions for managing and reducing mortality, particularly in vulnerable older populations. Further studies are warranted to determine the factors contributing to geographical disparity and treatment options.
キーワード
Population surveillance
Mortality
Nontuberculous mycobacterial infections
発行日
2025-09
出版物タイトル
International Journal of Infectious Diseases
158巻
出版者
Elsevier BV
開始ページ
107932
ISSN
1201-9712
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2025 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1016/j.ijid.2025.107932
ライセンス
http://creativecommons.org/licenses/by/4.0/
助成情報
22K10415: 医療データサイエンスによる高齢者医療の疾病構造に関する臨床疫学研究 ( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
( 公益財団法人大山健康財団 / Ohyama Health Foundation Inc. )